Zobrazeno 1 - 10
of 80
pro vyhledávání: ''
Autor:
Min Shi, Kari G. Rabe, Sameer A. Parikh, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Timothy G. Call, Paul J. Hampel, N. Nora Bennani, Amber B. Koehler, Wei Ding, Susan L. Slager, Eli Muchtar, Yucai Wang, Susan M. Schwager, Aref Al-Kali, Mithun Vinod Shah, Saad S. Kenderian, Jose F. Leis
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-6 (2021)
Blood Cancer Journal
Blood Cancer Journal
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-10 (2021)
Blood Cancer Journal
Blood Cancer Journal
Immunotherapy has shown efficacy in relapsed multiple myeloma (MM). However, these therapies may depend on a functional tumor immune microenvironment (iTME) for their efficacy. Characterizing the evolution of the iTME over the disease course is neces
Autor:
Ryul Kim, Sung Soo Yoon, Keonyong Lee, Nam Hoon Kwon, Yoosik Kim, Sunghoon Kim, Youngil Koh, Namseok Lee, Min A. Kim, Daeyoon Kim, Seulki Song, Dongchan Kim, Jayoung Ku
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
Communications biology, vol 3, iss 1
Communications Biology
Communications biology, vol 3, iss 1
Aminoacyl-tRNA synthetase-interacting multifunctional protein 2 (AIMP2) is a non-enzymatic component required for the multi-tRNA synthetase complex. While exon 2 skipping alternatively spliced variant of AIMP2 (AIMP2-DX2) compromises AIMP2 activity a
Autor:
Audrey Bidet, Hubert Serve, Pierre-Yves Dumas, Carsten Müller-Tidow, Josefina Serrano, Teresa Bernal, Sarah Bertoli, Juan Bergua, Eduardo Rodriguez Arbolí, Uwe Platzbecker, Pilar Martínez-Sánchez, Martin Bornhäuser, Eric Delabesse, Adolfo de la Fuente Burguera, Christian Recher, Arnaud Pigneux, Michael Kramer, Claudia D. Baldus, David Martínez-Cuadrón, Pau Montesinos, Emilie Bérard, Cristina Gil, Christoph Röllig, Suzanne Tavitian
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best treatment option remains controversial especially when choosing between intensive chemotherapy and hypomethylating agents. We set up a multicentric Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4fd2308cc3bead0a723ebfdc6b70e7
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15187
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15187
Autor:
Gareth J. Morgan, Naveen Yarlagadda, Meera Mohan, Shayu Deshpande, Pingping Qu, Carolina Schinke, Maliha Khan, Katie R. Ryan, Bart Barlogie, Yan Wang, Antje Hoering, Eileen M Boyle, Maurizio Zangari, Brian A Walker, Sharmilan Thanendrarajan, Faith E. Davies, Cody Ashby, Samrat Roy Choudhury, Frits van Rhee, Christopher P. Wardell, Valeriy V. Lyzogubov
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 6, Pp 1-9 (2020)
Blood Cancer Journal
Blood Cancer Journal
Primary plasma cell leukemia (pPCL) is a rare and aggressive form of multiple myeloma (MM) that is characterized by the presence of ≥20% circulating plasma cells. Overall survival remains poor despite advances of anti-MM therapy. The disease biolog
Autor:
Raphael Mwangi, Priyanka A. Pophali, Ellen D. McPhail, Rhett P. Ketterling, Lisa M. Marinelli, Paul J. Kurtin, Reid G. Meyer, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 1, Pp 1-9 (2020)
Blood Cancer Journal
Blood Cancer Journal
While MYC translocations in B-cell lymphoma (BCL) have been extensively studied, the significance of MYC amplification (MYC amp) is poorly understood. This study characterizes BCL showing MYC amp, defined as uncountable FISH signals. Retrospective an
Autor:
Feng Wang, Naveen Pemmaraju, Li Zhao, Maliha Khan, Tianyu Cai, Hannah C. Beird, Marina Konopleva, Mansour Alfayez, P. Andrew Futreal, Joseph D. Khoury
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 12, Pp 1-9 (2019)
Blood Cancer Journal
Blood Cancer Journal
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, male-predominant hematologic malignancy with poor outcomes and with just one recently approved agent (tagraxofusp). It is characterized by the abnormal proliferation of precursor plasmac
Autor:
Maximilian Merz, Anna Jauch, Peter Brossart, Jan Duerig, Hartmut Goldschmidt, Dirk Hose, Steffen Luntz, Britta Besemer, Elias K. Mai, Ahmet H. Elmaagacli, Anja Seckinger, Markus Munder, Stephan Fuhrmann, Hans-Walter Lindemann, Uta Bertsch, Marc S. Raab, Igor Wolfgang Blau, Christian Jehn, Hans Salwender, Katja Weisel, Axel Benner, Kaya Miah, Mathias Haenel, Christof Scheid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3e93f399758e8aa52c01b85b8ed62d
https://hdl.handle.net/20.500.14017/a78230dc-1b15-42b4-b98b-770e800164f1
https://hdl.handle.net/20.500.14017/a78230dc-1b15-42b4-b98b-770e800164f1
Autor:
Kate Reed, Edmond J. Breen, Ben R. Herbert, Douglas H. Campbell, Parisa Asvadi, Michael Copeman, Rosanne Dunn, Patricia Walker, Andrew Spencer
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 8, Pp 1-5 (2019)
Blood Cancer Journal
Blood Cancer Journal
Autor:
Silke Heidenreich, Uwe Platzbecker, Marie Robin, Dietger Niederwieser, Dietrich W. Beelen, Arnon Nagler, Arnold Ganser, Johan Maertens, Arne Brecht, Nicolaus Kröger, Per Ljungman, Johannes Schetelig, Gérard Socié, Matthias Stelljes, Linda Koster, Antonin Vitek, Michel van Gelder, Liesbeth C. de Wreede, Jürgen Finke, Ghulam J. Mufti, Liisa Volin, Guido Kobbe, Ibrahim Yakoub-Agha, Thomas Luft
Publikováno v:
Leukemia, 33(3), 686-695. Nature Publishing Group
Leukemia
Leukemia, 33(3), 686-695
Leukemia
Leukemia, 33(3), 686-695
The causes and rates of late patient-mortality following alloHCT for myelodysplastic syndromes or secondary acute myeloid leukemia were studied, to assess the contribution of relapse-related, treatment-related, and population factors. Data from EBMT